BBC • 10/22/2026 – 10/23/2026

L'Oreal's CEO has stated that the use of GLP-1 weight loss drugs is significantly affecting beauty and skin care sales. He described this trend as "a very important phenomenon" for the company.
Advertisement
Stories gain Lindy status through source reputation, network consensus, and time survival.












